SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (23329)7/18/1998 3:15:00 AM
From: Henry Niman  Respond to of 32384
 
ONTAK should be on the market this year. Panretin topical should be on the market by the beginning of next year. Targretin oral and topical should be on the market by the middle of next year. Panretin oral should be on the market by the end of next year.



To: Hippieslayer who wrote (23329)7/18/1998 9:50:00 AM
From: tonyt  Read Replies (1) | Respond to of 32384
 
>Which 5 drugs should be on the market by next year?

Givin this 'fact', don't you think that the market would give LGND a higher value than $12.25? (Hell, the market gives AMZN value in the triple digits, and they don't have projected earnings until '01!!)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News